Publication

Updated toxicity profile and relapse-free survival outcomes using an adapted pyrexia management algorithm in patients with resected stage III BRAF V600E/K-mutant melanoma treated with adjuvant dabrafenib plus trametinib in COMBI-APlus

Del Vecchio, M.
; 
Atkinson, V. G.
; 
Ryll, B.
; 
Menzies, A. M.
; 
Aubin, F.
; 
Sileni, V. C.
; 
Ferraresi, V.
; 
Lesimple, T.
; 
Rinaldi, G.
; 
Saiag, P.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Del Vecchio, M.
Atkinson, V. G.
Ryll, B.
Menzies, A. M.
Aubin, F.
Sileni, V. C.
Ferraresi, V.
Lesimple, T.
Rinaldi, G.
Saiag, P.
Robert, C.
Dutriaux, C.
Gogas, H. J.
Demidov, L.
Gupta, Avinash
Banerjee, H.
Sudhir, S.
Miranda, F.
Lau, M. R.
Grob, J. J.
Affiliation
Department Of Medical Oncology And Hematology, Unit of Melanoma Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, 20133 - Milan
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Del Vecchio M, Atkinson VG, Ryll B, Menzies AM, Aubin F, Sileni VC, et al. Updated toxicity profile and relapse-free survival outcomes using an adapted pyrexia management algorithm in patients with resected stage III BRAF V600E/K-mutant melanoma treated with adjuvant dabrafenib plus trametinib in COMBI-APlus. Annals of Oncology. 2022 Sep;33(7):S914-S. PubMed PMID: WOS:000866211601077.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/625965
Embedded videos